Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Coherus BioSciences, Inc. (CHRS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
SC 13G/A
| BlackRock Inc. reports a 10.9% stake in COHERUS BIOSCIENCES INC |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 0% stake in Coherus BioSciences, Inc. |
| 02/03/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/18/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 7% stake in Coherus BioSciences, Inc. |
| 02/14/2022 |
SC 13G/A
| ALLIANCEBERNSTEIN L.P. reports a 7.4% stake in Coherus Biosciences Inc |
| 02/09/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/27/2022 |
SC 13G/A
| BlackRock Inc. reports a 15.5% stake in COHERUS BIOSCIENCES INC |
| 01/26/2022 |
SC 13G/A
| BlackRock Inc. reports a 15.5% stake in COHERUS BIOSCIENCES INC |
| 01/07/2022 |
SC 13G/A
| JPMORGAN CHASE & CO reports a 8.2% stake in Coherus BioSciences, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/26/2021 |
SC 13G/A
| BlackRock Inc. reports a 14.6% stake in COHERUS BIOSCIENCES INC |
| 06/09/2020 |
SC 13G/A
| BlackRock Inc. reports a 14.3% stake in COHERUS BIOSCIENCES INC |
| 02/07/2020 |
SC 13G/A
| Temasek Holdings Ltd reports a 10.5% stake in Coherus BioSciences, Inc. |
| 02/05/2020 |
SC 13G/A
| BlackRock Inc. reports a 8.1% stake in COHERUS BIOSCIENCES INC |
| 01/10/2020 |
SC 13G/A
| FMR LLC reports a 1.4% stake in COHERUS BIOSCIENCES INC |
| 01/06/2020 |
SC 13G/A
| JPMORGAN CHASE & CO reports a 4.9% stake in Coherus BioSciences, Inc. |
| 11/08/2019 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 3.4% stake in Coherus BioSciences, Inc. |
| 02/14/2019 |
SC 13G/A
| HEALTHCARE ROYALTY PARTNERS III, L.P. reports a 4.7% stake in Coherus BioSciences, Inc. |
| 02/13/2019 |
SC 13G/A
| Daiichi Sankyo Company, LTD reports a 0% stake in COHERUS BIOSCIENCES INC. |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/04/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| Lilly Ventures Fund I LLC reports a 0% stake in Coherus BioSciences, Inc. |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2018 |
SC 13G/A
| FMR LLC reports a 11.5% stake in COHERUS BIOSCIENCES INC |
| 02/12/2018 |
SC 13G/A
| Lanfear Dennis M reports a 5.8% stake in Coherus BioSciences, Inc. |
| 02/08/2018 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 12.5% stake in Coherus BioSciences, Inc. |
| 02/14/2017 |
SC 13G/A
| HEALTHCARE ROYALTY PARTNERS III, L.P. reports a 7.1% stake in Coherus BioSciences, Inc. |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/14/2017 |
SC 13G/A
| Lilly Ventures Fund I LLC reports a 5.9% stake in Coherus BioSciences, Inc. |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
|
|
|